Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
In brief
JNJ's acquisition of Firefly Bio advances its oncology innovation, but comes with a short-term earnings dilution.
ClearTape summarizes context in-app. For the full publisher article, use Read original source above.